SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending after receiving FDA approval for its motion sickness drug, NEREUS, marking the first new treatment in this category in decades. The community is actively discussing the significant upside potential, fueled by this approval and upcoming PDUFA dates for other pipeline candidates, with many highlighting its potential off-label use for GLP-1 induced nausea. Traders are debating whether to hold for long-term growth driven by a diversified portfolio or capitalize on immediate short-term volatility.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull Corp ($BULL) is trending amid intense community debate, largely driven by ongoing price depreciation attributed to tax loss harvesting and persistent selling pressure from SPAC-related share overhang. Despite recent inclusion in the Russell 2000/3000 indexes and reported strong revenue growth in its latest quarter, sentiment remains highly polarized. Bulls view the stock as deeply undervalued with significant long-term potential from user growth and international expansion, while bears warn of continued dilution and question the company's valuation.

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai is trending due to significant community discussion surrounding an ongoing, repeatedly postponed proxy vote on share authorization, creating considerable market uncertainty. Investors are sharply divided, with many expressing frustration over potential dilution and management's communication, while others advocate for the shares as crucial for strategic acquisitions like Ask Sage and future growth. Despite current price stagnation, a core of optimism persists for the company's potential to secure substantial government contracts and leverage its AI capabilities within the defense and national security sectors.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE CRYPTO is a top trending meme coin, fueled by an exceptionally active community passionately advocating its status as an "OG meme" originating from Rage Comics. This dedicated base is consistently building out an ecosystem with projects like RageMaker and RageGames, expressing strong conviction for substantial long-term growth and widespread recognition in the crypto space. They are frequently seen battling other meme coins for trending dominance and market attention.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is trending amid sharp investor division, primarily driven by the recent FDA approval of Novo Nordisk's oral Wegovy pill and speculation around potential distribution partnerships for GLP-1 treatments. While many note the stock's significant drawdown and high short interest as bearish indicators, others view the current valuation as a prime long-term buying opportunity, citing strong fundamentals, institutional accumulation, and the company's expansion into new health verticals and international markets. The community is actively debating whether the current dip sets the stage for a short squeeze or further decline for the direct-to-consumer telehealth provider.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid Group is trending amidst growing investor frustration as the stock continues to mark new lows, fueling intense debate around its management team and the prolonged absence of a permanent CEO. The community is actively discussing the disconnect between the acclaimed vehicle technology and the company's market performance, with many questioning impending production targets and speculating on potential short squeezes or further strategic shifts.

Dogecoin is a cryptocurrency based on the popular "Doge" Internet meme and features a Shiba Inu on its logo. Dogecoin is a Litecoin fork. Introduced as a "joke currency" on 6 December 2013, Dogecoin quickly developed its own online community and reached a capitalization of US$60 million in January 2014. Compared with other cryptocurrencies, Dogecoin had a fast initial coin production schedule: 100 billion coins were in circulation by mid-2015, with an additional 5.256 billion coins every year thereafter. As of 30 June 2015, the 100 billionth Dogecoin had been mined.   Dogecoin was created by Billy Markus from Portland, Oregon and  Jackson Palmer from Sydney, Australia. Both wanted to create a fun cryptocurrency that will appeal beyond the core Bitcoin audience. Dogecoin is primarily used as a tipping system on Reddit and Twitter where users tip each other for creating or sharing good content. The community is very active in organising fundraising activities for deserving causes.  The developers of Dogecoin haven’t made any major changes to the coin since 2015. This means that Dogecoin could get left behind and is why Shibas are leaving Dogecoin to join more advanced platforms like Ethereum. One of Dogecoin strengths is its relaxed and fun-loving community. However, this is also a weakness because other currencies are way more professional.  To purchase Dogecoin, it involves downloading a crypto wallet, setting up a crypto exchange account and then trading away for your desired crypto currency. Once we have set up an account with a DOGE currency exchange and deposited some funds, you are ready to start trading.

Dogecoin

Dogecoin is currently seeing divided community sentiment, with many anticipating a potential rebound in the new year following year-end tax loss selling. Enthusiasts are holding strong, highlighting its robust community and long-term potential, while critics dismiss it as a "shit coin" with no utility. This dynamic conversation reflects the ongoing speculation about its future trajectory within the volatile crypto market.

Ekso Bionics Holdings, Inc. engages in the provision of design, development, and sale of exoskeleton technology that currently has applications in healthcare and industrial markets. The company was founded on January 30, 2012 and is headquartered in San Rafael, CA.

Ekso Bionics Holdings Inc

Ekso Bionics Holdings is capturing market attention following a proposed business combination with Applied Digital, which would see Applied Digital's cloud GPU business spun off into ChronoScale, an AI compute platform. The potential "AI merger" is fueling fervent discussion among traders, with many anticipating a significant run due to the stock's low float, while others express concerns about potential shareholder dilution.

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.

Corcept Therapeutics Inc

Corcept Therapeutics is at the center of investor attention with a highly anticipated regulatory decision for its Cushing's syndrome drug, relacorilant, prompting intense community debate and significant trading volume. Traders are closely watching for an approval or a potential Complete Response Letter, weighing recent sector approvals against CORT's price action and broader pipeline, including its ovarian cancer program, which fuels long-term bullish sentiment despite short-term uncertainty.

NovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. Its products include Avenova, NeutroPhase and DERMAdoctor. The company was founded on January 19, 2000 and is headquartered in Emeryville, CA.

Novabay Pharmaceuticals Inc

Novabay Pharmaceuticals is gaining significant attention following its substantial special cash dividend and a strategic shift towards evaluating blockchain-based assets, sparking both bullish excitement and investor debate. The community is actively discussing the stock's impressive rally, with many weighing short squeeze potential against concerns of a pump-and-dump scenario fueled by future dilution or offerings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

4 Top-Ranked ETF Areas That Beat the Market in 2025

Top-ranked ETF areas that beat SPY in 2025 included semiconductors, Japan, financials and pharma. Winning ETFs were FTXL, EWJV, KBWB and IHE.



M&A: An Overlooked ETF Investing Zone of AI Boom?

AI-driven data-center dealmaking is surging. ETFs like MNA, IAI, KBWB, CHAT offer ways to tap the M&A boom tied to AI infrastructure.

M&A Deals Thriving in 2025: ETFs in Focus

M&A deals are booming in 2025 despite fewer transactions -- megadeals, AI bets and Fed cuts may fuel ETFs like MNA, IAI, KBWB & CHAT.

Should You Invest in the SPDR S&P Capital Markets ETF (KCE)?

Former U.K. Prime Minister Rishi Sunak’s return to Wall Street as a Senior Adviser at Goldman Sachs (GS) has drawn scrutiny from the U.K.’s Advisory Committee on Business Appointments, which warned Tuesday that the role could be perceived as offering the bank “unfair access and influence” within government.Sunak’s appointment at Goldman marks his return to Wall Street more than two decades after leaving. Sunak, who is still a member of parliament in the U.K., worked at Goldman as an analyst from 2001 to 2004 – first as a summer intern, then as a junior analyst.<a href="http://stocktwits.com/symbol/GS">Goldman’s stock</a> fell 1.4% in midday trade on Tuesday after the announcement amid broader market weakness. On Stocktwits, retail sentiment around the stock fell to ‘bullish’ territory from ‘extremely bullish’ a week ago.This comes after HSBC adopted a “more cautious stance” on bank stocks on Tuesday and reduced its rating on Goldman to ‘Reduce’ from ‘Hold’ with a $627 price target.In a letter published alongside Goldman’s announcement, Acoba said Sunak’s appointment presents a risk of “overlap” with responsibilities he held while serving as Prime Minister and Chancellor.&nbsp;The watchdog imposed restrictions that prohibit Sunak from lobbying the U.K. government on Goldman’s behalf or advising the bank on matters related to government contracts for 12 months from his last day in the ministerial office.Sunak has largely stayed out of public view since his Conservative Party suffered a historic defeat in the July 2024 general election, dropping from 365 seats to 121.&nbsp;His appointment adds to a growing list of former senior politicians taking roles in finance, where their regulatory insight and global networks are viewed as strategic assets.“In his role, he [Rishi Sunak] will work with leaders across the firm to advise our clients globally on a range of important topics, sharing his unique perspectives and insights on the macroeconomic and geopolitical landscape,” said Goldman Sachs Chairman and CEO David Solomon.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/bofa-hikes-s-and-p-500-forecast-flags-slowing-tech-profits-apple-meta-amazon/chFvs0hR5WP">BofA Hikes S&amp;P 500 Forecast, Flags Slowing Tech Profits – But Wall Street Boosts Price Targets For Apple, Meta, Amazon Ahead Of Q2 Earnings</a>

Prime Minister Rishi Sunak speaks during the launch of the Welsh Conservatives General Election manifesto on June 21, 2024 in Rhyl, United Kingdom. (Photo by Leon Neal/Getty Images)

Rishi Sunak’s Return To Goldman Sachs Draws Warning From UK Watchdog

Former U.K. Prime Minister Rishi Sunak’s appointment at Goldman Sachs at Senior Adviser marks his return to Wall Street more than two decades after leaving. 

Equity

5 American ETFs Witnessing Gains Ahead of Independence Day

SHLD, ARKW, BUZZ and other U.S. ETFs are seeing gains ahead of July 4.


Is SPDR S&P Capital Markets ETF (KCE) a Strong ETF Right Now?

Should You Invest in the iShares U.S. Broker-Dealers & Securities Exchanges ETF (IAI)?

Morgan Stanley (MS) is expected to be on retail radar on Wednesday after reports said the bank plans to lay off about 2,000 employees later this month.<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2025-03-18/morgan-stanley-plans-about-2-000-job-cuts-to-keep-a-lid-on-costs">Bloomberg reported</a> on Tuesday that the job cuts, the first significant workforce reduction under CEO Ted Pick, would take place across the firm, except for its roughly 15,000 financial advisers.The report, citing people familiar with the matter, stated that the plans to trim its workforce were drafted before recent market volatility. The bank has more than 80,000 employees.The Bloomberg report said that the move is aimed at reining costs as executives grapple with minimal attrition in their ranks.The report said some of the upcoming cuts are linked to performance while others are the result of changes in where the firm bases some of its workers.A small part of the affected jobs reflects the impact of artificial intelligence and automation inside the Wall Street bank, a trend that would drive a rising portion of job reductions in the coming years, the report said, citing one of the people.Financial institutions in the U.S. are navigating tumultuous market conditions as tariff threats have renewed concerns of a recession.According to The Fly, Erste Group downgraded Morgan Stanley earlier this month. The brokerage noted the bank’s investment banking segment, particularly, is suffering from increased uncertainty caused by the current U.S. tariff policy and weak economic growth.Retail sentiment on Stocktwits remained in the ‘neutral’ (45/100) territory in the early hours, while retail chatter was ‘normal.’<figure class="image"><img style="aspect-ratio:725/160;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/MS_March_19_JPG_5d0a4e7ad7.webp" alt="MS’s Sentiment Meter and Message Volume as of 04:21 a.m. ET on March 19, 2025 | Source: Stocktwits" width="725" height="160"><figcaption>MS’s Sentiment Meter and Message Volume as of 04:21 a.m. ET on March 19, 2025 | Source: Stocktwits</figcaption></figure><a href="https://stocktwits.com/symbol/MS">Morgan Stanley shares</a> have fallen about 6% year-to-date (YTD). They have fallen more than 16% over the past month.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/surf-air-mobility-stock-rises-after-hours-on-upbeat-q4-revenue-retail-s-split/ch7kQHWRb29">Surf Air Mobility Stock Rises After-Hours On Upbeat Q4 Revenue, Retail’s Split</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Morgan Stanley logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

Morgan Stanley In Spotlight After Reports Of Workforce Reduction, Retail’s Yet To React

A Bloomberg report said that the move is aimed at reining costs as executives grapple with minimal attrition in their ranks.

Morgan Stanley In Focus After Reports Of Workforce Reduction

How Is S&P Global's Stock Performance Compared to Other Broker-Dealers & Securities Exchanges Stocks?

S&P Global has outperformed its industry peers recently, and analysts remain highly optimistic about the stock’s prospects.

Current Price	$181.17
Prev Close	$182.57
Open	$182.98
Dividend Yield	N/A
50-Day Moving Average	$175.79
Beta	N/A
Avg. Volume	169,249.68
PE Ratio	N/A

52-Week High	$184.13
52-Week Low	$116.88
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

IAI
iShares U.S. Broker-Dealers ETF

Feed

News

Sentiment

Fundamentals

Info

Latest IAI News

IAIiShares U.S. Broker-Dealers ETF